ABSTRACT During embryonic development, the proepicardial organ (PEO) grows out over the heart surface to form the epicardium. Following epithelial-mesenchymal transformation, epicardium-derived cells (EPDCs) migrate into the heart and contribute to the developing coronary arteries, to the valves, and to the myocardium. The peripheral Purkinje fiber network develops from differentiating cardiomyocytes in the ventricular myocardium. Intrigued by the close spatial relationship between the final destinations of migrating EPDCs and Purkinje fiber differentiation in the avian heart, that is, surrounding the coronary arteries and at subendocardial sites, we investigated whether inhibition of epicardial outgrowth would disturb cardiomyocyte differentiation into Purkinje fibers. To this end, epicardial development was inhibited mechanically with a membrane, or genetically, by suppressing epicardial epithelial-to-mesenchymal transformation with antisense retroviral vectors affecting Ets transcription factor levels (n ¼ 4, HH39-41). In both epicardial inhibition models, we evaluated Purkinje fiber development by EAP-300 immunohistochemistry and found that restraints on EPDC development resulted in morphologically aberrant differentiation of Purkinje fibers. Purkinje fiber hypoplasia was observed both periarterially and at subendocardial positions. Furthermore, the cells were morphologically abnormal and not aligned in orderly Purkinje fibers. We conclude that EPDCs are instrumental in Purkinje fiber differentiation, and we hypothesize that they cooperate directly with endothelial and endocardial cells in the development of the peripheral conduction system. Anat
. Photomicrographs of representative transverse sections of a normal control quail heart (HH41; a, d, g, and j), a quail heart with a mechanical inhibition of epicardial outgrowth (inh; HH41; b, e, h, and k), and a chicken heart with hampered EPDC differentiation due to retrovirally induced downregulation of Ets-1 and Ets-2 (asEts; HH41; c, f, i, and l). a-c show haematoxylin-eosin-stained overviews of the sections, at approximately mid-ventricular level. Boxed areas in a-c delineate the regions depicted in d-f. Serial sections were stained for Purkinje fiber cells with the EAP-300 antibody (in green) and nuclei were stained with DAPI (in blue). In the control heart (d and g), normal development of the periarterial (arrows) and subendocardial (arrowheads) Purkinje fiber cells was observed. In contrast, in the inhibition embryo (e and h) and in the asEts-1/2 embryo (f and i), we observed a decrease in Purkinje fiber cell numbers. The details (g-i; boxed areas in d-f) show periarterially located Purkinje fiber cells. In embryos with disturbed epicardial contribution, EAP-300-positive cell numbers were dramatically reduced compared to normal embryos. Quantification of the area occupied by periarterial Purkinje fibers was performed as described in text, in sections like these, comparing coronary arteries of similar diameter. j-l show the 1A4 (smooth muscle actin) staining in consecutive sections of g-i. The smooth muscle cell layer of the coronary arteries (CA) was slightly thinner in this mechanically PEO-inhibited embryo (k). However, this was not a consistent finding. Also, the asEts-1/2 embryos displayed coronary arteries with normal thickness of the smooth muscle cell layer (l). CA, coronary artery; IVS, interventricular septum; LV, left ventricle; RV, right ventricle. Scale bars ¼ 250 mm (d-f); 50 mm (g-l).
subepicardial layer. These epicardium-derived cells (EPDCs) can migrate into the myocardium and differentiate into interstitial, subendocardial, and coronary adventitial fibroblasts, as well as coronary smooth muscle cells Vrancken Peeters et al., 1999) . Several studies have demonstrated crucial roles of EPDCs in the formation of the compact myocardium (Kwee et al., 1995; Yang et al., 1995; Gittenberger-de Groot et al., 2000; Lie-Venema et al., 2003) and coronary development , while a morphogenic role for EPDCs in valve development has also been postulated , 2003a .
Retroviral tagging experiments showed that the Purkinje fibers of the peripheral conduction system differentiate from cardiomyocytes, in close spatiotemporal relation to the developing coronary vasculature Hyer et al., 1999) , whereas the subendocardial Purkinje fibers develop in the proximity of endocardial cells. These unique differentiation sites suggested an inductive role both for periarterial and subendocardial EPDCs and for a paracrine signal from the endocardium and arterial beds in the recruitment of cardiomyocytes into the Purkinje fiber network (Gittenberger-de Groot et al., 2003b; Gourdie et al., 2003) . Recent experimentation showed that Purkinje fiber differentiation is tightly regulated by hemodynamic alterations, while mature endothelin-1 (ET-1) and ET-converting enzyme 1 (ECE1) were identified as inductive molecules (Takebayashi-Suzuki et al., 2000; Reckova et al., 2003; Hall et al., 2004) . Concomitant retroviral expression of mature ET-1 and ECE1 was even sufficient for the ectopic conversion of adjacent cardiomyocytes into Purkinje fibers (Takebayashi-Suzuki et al., 2000) . Because interstitial EPDCs are present throughout the myocardium , even the ectopically converting cardiomyocytes could have been influenced by a juxtaposed EPDC.
In the present study, we tested the hypothesis that EPDCs play a role in the differentiation of the Purkinje fibers by morphologic analysis of the conductive network after mechanical and genetic disturbance of epicardial development.
MATERIALS AND METHODS
To study the role of EPDCs in the development of Purkinje fibers, we used a mechanical and a genetic experimental model in which EPDC development and differentiation were disturbed. From earlier work, we knew that with either model the extent of epicardial disturbance is variable (Lie-Venema et al., 2003; Eralp et al., 2005) . For close immunohistochemical examination, we specifically chose the embryos (n ¼ 7) without large morphological and coronary aberrations to ensure that our analysis would focus on the influence of disturbed or delayed epicardial outgrowth rather than on the influence of impaired coronary formation on Purkinje fiber development. Normal controls consisted of untreated Japanese quail embryos (Coturnix coturnix japonica; n ¼ 7) from Hamburger and Hamilton (HH) stages 39 to 42 (Hamburger and Hamilton, 1951) .
Mechanical Inhibition of Epicardial Outgrowth
Outgrowth of the PEO in quail embryos (HH15 to HH18; n ¼ 15) was inhibited by placing a piece of egg shell membrane between the PEO and the heart tube, as described before (Mä nner, 1993; Eralp et al., 2005) . After reincubation at 37.58C (80% humidity), embryos were isolated at stages HH40-HH42.
Genetic Inhibition of Epicardial Development
In earlier work, we established that epicardial development could be impaired by antisense downregulation of the Ets-1 and Ets-2 transcription factors in chicken embryos (Lie-Venema et al., 2003) . In this model, Ets-1 and Ets-2 expression were downregulated simultaneously in vivo. In short, white Leghorn chicken embryos (Gallus domesticus) were injected with the retroviral CXasetsIZ construct via the right anterior vitelline vein at developmental stage HH14/HH15 as described earlier (Lie-Venema et al., 2003) . Four embryos of developmental stage HH39-HH41 were analyzed.
Immunohistochemistry
Isolation and processing of embryos for immunohistochemistry were done as described earlier (Vrancken Peeters et al., 1997) . Serial sections were produced and subjected to standard immunohistochemical procedures (Poelmann et al., 1993; Vrancken Peeters et al., 1997) . For analysis of Fig. 2 . Quantification of periarterial Purkinje fiber hypoplasia in embryos with mechanical and retrovirally induced inhibition of epicardial outgrowth. The size of the area occupied by EAP-300-positive cells was determined as described in text. Significant (P < 0.05) reduction of the periarterial Purkinje fiber area was observed in both experimental groups (mechanical inhibition: 10.4% 6 2.7%, gray bar; genetic inhibition: 8.3% 6 1.4%, black bar) compared to control embryos (100% 6 3.8%, white bar). Error bars indicate standard deviations. coronary vessel development, we used the a-actin smooth muscle antibody 1A4 (Sigma, St. Louis, MO, 1:3,000).
For detection of Purkinje fibers, we used the EAP-300 antibody (McCabe et al., 1995) diluted 1:200. The size of the area occupied by fluorescent EAP-positive cells was determined in five vessels of comparable diameter in the interventricular septum of the control and experimental groups (three embryos per group). To maintain and enhance the signal of the secondary FITC-labeled antibody after immunofluorescent data acquisition, sections of interest were incubated with antifluorescein antibody Fab fragment conjugated with peroxidase (Converter-POD; Roche Diagnostics, Mannheim, Germany). In paraformaldehydefixed tissues, this resulted in better signal-to-background ratios than the use of immunofluorescence alone. Apoptosis in the Purkinje fibers was assessed as described earlier .
Statistical Analysis
Data were represented as average 6 standard deviation. A nonpaired two-tailed Student's t-test was used for statistical comparison. A P value less than 0.05 was considered statistically significant.
RESULTS
To assess the role of EPDCs in Purkinje fiber development, we used two independent avian models in which epicardial development was disturbed. The severity of the cardiac abnormalities in these models is closely related to the degree of epicardial outgrowth inhibition. Especially the procedure for mechanical PEO inhibition yields embryos in which epicardial development is disturbed in variable degrees . This results in a broad range of malformations, varying from complete absence of the epicardium and embryonic lethality around stage HH29 (Gittenberger-de Groot et al., 2000) to only a delay in epicardial outgrowth with a mild cardiac phenotype and survival until hatching at stage 46. The peripheral Purkinje fiber conduction system develops rather late in embryonic life, from stage HH36 onward. Thus, the manipulated embryos surviving beyond stage HH39 that were used for this study were typically those that were only mildly affected by the inhibition procedure: both in the mechanical and in the genetic inhibition model.
Purkinje Fiber Development in Embryos With a Mechanical Inhibition of Epicardial Outgrowth
In the embryos with mechanically inhibited epicardial outgrowth that succeeded to survive beyond developmental stage HH40, severe cardiac malformations were not observed except for an occasional reduction in heart size. However, immunofluorescent staining with the EAP-300 antibody, specific for avian conduction tissue (McCabe et al., 1995) , showed that both the periarterial and the subendocardial Purkinje fibers were affected in these embryos. To quantify the hypoplasia of the periarterial Purkinje fibers (Fig. 1) , fluorescently stained areas occupied by the periarterially located Purkinje fibers were measured in 15 vessels with a comparable diameter (5 in each of three embryos) located in the interventricular septum, at approximately mid-ventricular level in both the experimental and control groups. Because the periarterial occupancy with EAP-300-positive cells may vary between the vessels within the same heart, we analyzed the arteries with the most EAP-300 cells, both in control and experimental embryos. The EAP-300-postitive area was found to be reduced by up to 89% (P < 0.05; Figs. 1g-i and 2 ). Hypoplasia of the periarterial Purkinje fiber network appeared to be the result of a reduction in the number of EAP-300-positive cells, whereas the amount of EAP-300 signal per cell was not altered significantly in the immunofluorescent stainings.
To ensure that our analysis would focus on the influence of disturbed or delayed epicardial outgrowth rather than on the influence of impaired coronary formation on Purkinje fiber development, we selected five embryos with a normal distribution of the coronary arteries for a more detailed morphological analysis of the periarterial and subendocardial Purkinje fibers. Whereas we could observe hardly any green fluorescein signal above background by immunofluorescence microscopy (not shown), antifluorescein signal enhancement and conventional immunohistochemistry revealed a faint EAP-300 signal around the coronary arteries in these embryos ( Fig. 3c  and d) . The coronaries were surrounded by a normal amount of 1A4-positive smooth muscle cells (not shown). In addition, cellular morphology seemed abnormal, especially in the subendocardially located Purkinje fibers. Whereas in normal embryos cells of the subendocardial Purkinje fibers were aligned in continuous fiber-like strands, in the inhibition embryos they were abnormally large, rounded, and had failed to differentiate into a coherent Purkinje fiber network (Fig. 3) .
Purkinje Fiber Development in Embryos With Genetic Inhibition of Epicardial Outgrowth
To show that the Purkinje fiber hypoplasia observed after PEO inhibition with a piece of eggshell membrane did not depend on this particular inhibition model, we confirmed the results in the genetic inhibition model available in our group. Retrovirally delivered antisense Ets-1/2 has Fig. 3 . Photomicrographs of representative transverse sections of a normal control quail heart (HH 41; a, c, e, g, and i) and a quail heart with mechanical inhibition of epicardial outgrowth (inh; HH 41; b, d, f, h, and j). Sections were stained with immunofluorescent EAP-300 antibody and DAB-converted as described in text (c-j). a and b show the complete sections at approximately mid-ventricular level, where coronary arteries of similar diameter are present. The location of the enlargements in c-j is indicated. In the mechanically inhibited heart, the periarterial EAP-300 signal is faint and diffuse (d) when compared to the signal in the periarterial Purkinje fibers in the normal control heart (c). This is consistent with the finding that EAP-300 immunofluorescence did not surpass background in these embryos (Fig. 2) . Additionally, EAP-300 staining revealed abnormally large rounded cells in the subendocardial compartment of the peripheral conduction system. These cells were not as neatly organized in fibers as the EAP-300-positive cells in controls (e and f, left ventricular; g and h, right ventricular ventral free walls). Hyperplasia and absence of fiber-like organization of the subendocardial Purkinje fibers was observed throughout and is illustrated here by EAP-300 staining in the moderator band of the right ventricle (I and j, lateral side of the moderator band). CA, coronary artery, E, endothelium; LV, left ventricle; M, myocardium; PF, Purkinje fiber; RV, right ventricle. Scale bars ¼ 20 mm. been shown to decrease the contribution of EPDCs to heart formation by blocking epicardial epithelial-mesenchymal transformation (Lie-Venema et al., 2003) . In the four embryos transduced with the CXasEtsIZ retrovirus (antisense-Ets embryos, HH39-41), there were no gross morphologic abnormalities, coronary architecture and myocardial thickness were within the normal range, and there was some subepicardial mesenchyme present in the atrioventricular groove. By this, they were classified as being only mildly affected by the retroviral manipulation of epicardial EMT. Similar to the observations in the mechanically inhibited embryos, a marked reduction (up to 92%, P < 0.05) of periarterially located Purkinje fibers was found (Figs. 1i and 3) . Also resembling those in the mechanically inhibited embryos were the large rounded subendocardial EAP-300-positive cells that failed to form continuous strands (not shown).
DISCUSSION
Proper timing of the development of the epicardium and sequential transformation of the epicardium into migratory EPDCs is important for cardiac development. It has been shown that EPDCs are essential for formation of the compact myocardium (Gittenberger-de Groot et al., 2000; Tevosian et al., 2000; Lie-Venema et al., 2003; Eralp et al., 2005) , and that proepicardial organ-derived endothelial precursor cells and EPDCs provide the building blocks of the coronary vascular network (Poelmann et al., 1993; Vrancken Peeters et al., 1999; Lie-Venema et al., 2005) . Furthermore, EPDCs are involved in sculpting and remodeling of the outflow tract (Watanabe et al., 1999; Rothenberg et al., 2002) and have a key function in establishing the coronary orifices . The experimental results presented in this study provide the first direct evidence that EPDC are also directly involved in the development of the peripheral Purkinje fiber conduction system.
The recruitment of cardiomyocytes into the Purkinje fiber system has been demonstrated to be related to hemodynamic influences derived from the coronary vasculature and endocardial lining of the ventricular lumen Hyer et al., 1999) , with mature ET-1 and the ECE1 metalloprotease as key inductive factors (Takebayashi-Suzuki et al., 2000; Reckova et al., 2003; Hall et al., 2004) . Earlier work demonstrated dramatic effects on the development of cardiac architecture and coronary vasculature when epicardial differentiation was disturbed (Gittenberger-de Groot et al., 2000; Tevosian et al., 2000; Lie-Venema et al., 2003; Eralp et al., 2005) . However, the developmental effect of epicardial inhibition, either mechanically or genetically, is variable and the late surviving embryos (> HH39) in the present study were specifically included because they were the least affected.
This was not only deduced from the fact that they had been able to survive the critical developmental stage of HH35 (when the coronary ostia must have been formed), but also from their normal coronary and myocardial architecture. Accordingly, except for an occasional difference in the size of the hearts, no gross cardiac abnormalities were observed. We therefore advocate a direct effect of EPDCs on the conversion of cardiomyocytes into conduction cells and do not consider hemodynamic alterations to be the cause of the Purkinje fiber network hypoplasia in our experimental embryos. However, we cannot completely rule out this possibility in a minority of the embryos because of the slight concomitant thinning of the coronary smooth muscle layer. Our reasoning that EPDCs have a direct effect on Purkinje fiber formation is further substantiated by the abnormalities in the subendocardial portion of the peripheral conduction system.
We have not found evidence that increased apoptosis was the cause of the Purkinje fiber hypoplasia. Pruning of conduction tissue development by apoptotic events occurs specifically between stage HH29-32 in the future His bundle and bundle branches, and similar apoptotic pruning was suggested but not shown for the developing peripheral Purkinje fibers (Cheng et al., 2002) . It cannot be excluded that the apoptosis in the central conduction system is neural crest cell-related , whereas the peripheral Purkinje network has a specific relation with EPDCs (Gittenberger-de Groot et al., 2003b) . In embryos with epicardial outgrowth inhibition, we observed decreased, not increased, levels of apoptosis in the ventricular myocardium at stage HH30 . Additionally, in the present study, we did not find apoptotic cells in the Purkinje fiber network of both the normal and the PEOinhibited hearts at stage HH40 (not shown).
We can only speculate on the molecular mechanism by which EPDCs promote Purkinje fiber differentiation. We favor the idea of a direct paracrine effect of EPDCs on the cardiomyocytes to differentiate into Purkinje fibers, supported by the abnormalities of the subendocardial Purkinje fibers in our embryos. We propose a model in which EPDCs cooperate with endothelial cells in the differentiation of conductive tissue from cardiomyocytes (Fig. 4) . In our favorite hypothesis, EPDCs cause cardiomyocytes to change into more primitive cardiomyocytes. The fate of these EPDC-induced primitive cardiomyocytes (PCMs) is then determined by local factors, such as the ET-1 cleavage product of ECE1, which could as a second ''hit'' be delivered by endothelial or endocardial cells and cause the PCM finally to differentiate into a conductive cell of the Purkinje fiber network. Absence of or a decrease in either the first EPDC-derived or the second endothelial/endocardial cell-derived inductive event leads to hypoplasia of the Purkinje fiber network. In earlier studies demonstrating Fig. 4 . Hypothetical model for the role of EPDCs in the differentiation of Purkinje fibers. EPDCs derive from the epicardial mesothelium (gray outer layer) by epithelial-mesenchymal transition to form the subepicardial mesenchyme (stellate cells, gray). Following migration, these cells differentiate into periarterial smooth muscle cells (SMCs; in purple) and fibroblasts (spindle-shaped; in gray), myocardial interstitial fibroblasts (gray), and subendocardial fibroblasts (gray). Purkinje fiber cells (green) develop at (a) subendocardial and (b) periarterial sites, where both EPDCs (smooth muscle cells and/or fibroblasts) and endocardial/ endothelial cells (red) are in close proximity of the cardiomyocytes (pink) that convert into conduction tissue. c: Purkinje fiber cell (PC) differentiation occurs after two subsequent inductive ''hits.'' First, an EPDC-derived factor causes the cardiomyocyte (CM) to change into a more primitive cardiomyocyte (PCM). Thereafter, hemodynamically determined expression of ET-1 and ECE1 by endocardial/endothelial cells (EC) brings about the final signal that allows the primitive cardiomyocyte to convert into a conduction cell. Alternatively, the endothelial or endocardial cell instructs the EPDC to express one or more inductive factors. Among these, ET-1 is a candidate since it has been shown that cultured EPDCs can express this molecule (Eid et al., 1994) . the inductive capacities of endothelin and ECE-1 in Purkinje fiber conversion, the requirement for the initial EPDC-derived signal was fulfilled by the presence of interstitial EPDCs (fibroblasts) in either the cardiomyocyte culture in vitro or in vivo in the myocardium (Takebayashi-Suzuki et al., 2000) . It can also be hypothesized that the endocardial or endothelial cell would signal to the EPDC, which in turn would impose a directive signal on the neighboring cardiomyocyte. Alternatively, we can explain our findings with a model in which the levels of mature ET-1 are increased, either indirectly, by a cascade in which the EPDC instructs the endocardial/endothelial cell to enhance its ET-1 and/or ECE1 production, or directly, by the EPDCs. It has been shown that cultured EPDCs have ET-1 in their secretion repertoire (Eid et al., 1994) ; it remains to be investigated whether this also applies for EPDCs in vivo at the time of Purkinje fiber development.
Whatever mechanism it may turn out to be, the present study indicates that Purkinje fiber development is influenced by EPDCs within a narrow time window. We observed aberrant Purkinje fiber development in embryos with practically no morphological defects. The smooth muscle layer of the coronary arteries is comprised of differentiated EPDCs and because this layer is almost as good as normal in the inhibition embryos used in this study, it can be deduced that a drastic decrease of periarterial EPDCs does not account for the Purkinje fiber hypoplasia. During the procedure of mechanical inhibition of proepicardial outgrowth, we may well have induced only a delay in the time of arrival of the subendocardial and periarterial EPDCs, by destroying the extracellular matrix bridges connecting the PEO to the heart (Nahirney et al., 2003) while inserting a piece of eggshell membrane. When subsequently the piece of membrane failed to stay in place, PEO cells may have grown around the membrane and ''rescued'' the normal phenotype, except for an epicardial outgrowth delay of approximately 1 day with less noticeable developmental defects as a consequence. A similar phenomenon has been noted in PEO-inhibited chicken embryos rescued with a quail PEO inserted into the pericardial cavity. In these embryos, coronary ostia formation was disturbed . Preliminary electrographical experiments (not shown) indicating a concomitant decrease in action potential propagation from endocardium to epicardium implicate that such minor changes in EPDC behavior may have functional consequences as well, which is of particular interest from a clinical point of view.
In summary, we found that inhibition of epicardial outgrowth leads to morphological abnormalities of the Purkinje fiber network. We postulate that EPDCs, in close collaboration with endothelial and endocardial cells, play an essential role in the development of the peripheral conduction system of the heart. Our preliminary indications for electrocardiographical defects due to Purkinje fiber hypoplasia provide a basis for further research on the role of EPDCs in the development of congenital conduction deficits.
